Literature DB >> 2504805

Evaluation of the human gonadotroph free alpha-subunit secretory pools by administration of gonadotropin hormone-releasing hormone into normal subjects at different phases of the ovarian cycle.

M S Balin1, A Scommegna, R Benveniste.   

Abstract

The specificity of a monoclonal antibody RIA for the measurement of free alpha-subunit in plasma is presently documented. This RIA was used to explore the pituitary gonadotroph free alpha-subunit reserve in normal ovulating women stimulated with gonadotropin hormone-releasing hormone (GnRH). RIA specificity was established by means of competitive inhibition curves with various glycoprotein hormone preparations, and Sephadex G-100 exclusion chromatography of purified hFSH (1-2), hLH (LER 960) and pituitary extract. The 3.8% and 5.5% crossreactivities of hFSH 1-2 and hLH LER 960 were shown by exclusion chromatography to result in part from free alpha-subunit contamination in these purified preparations. Pituitary extract chromatography indicated hFSH and hLH cross-reactivity below 2.5% and 1.5%, respectively. Normal females were stimulated with GnRH throughout the cycle: 3 tests were performed on Day 7, 1 test on Day 13, 16, 17 and 22, respectively, and 2 tests on Day 24. GnRH stimulation consisted of an initial 100 micrograms bolus (time 0) followed at 2 h by a 12.5 micrograms/h constant infusion, and a second 100 micrograms bolus at 5 h. In all subjects, baseline free alpha-subunit values were below 2 ng/ml. Total free alpha-subunit secretion was markedly enhanced in subjects Day 13 and 16, in concert with total hLH and hFSH secretion. In the three subjects Day 7, free alpha-subunit was released only after the second GnRH bolus. In periovulatory subjects, free alpha-subunit secretion became apparent after the initial bolus and with constant GnRH infusion. In the three subjects Day 22 and 24, peak levels of free alpha-subunit were obtained after the second GnRH bolus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504805     DOI: 10.1007/bf03350705

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.

Authors:  G C Lachelin; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1978-03       Impact factor: 5.958

2.  Heterogeneity of purified human pituitary luteinizing hormone: effect on hormone measurement by radioimmunoassay.

Authors:  R Benveniste; L A Frohman; D Rabinowitz
Journal:  Endocrinology       Date:  1975-07       Impact factor: 4.736

3.  The specificity and application of a radioimmunoassay for the alpha-subunit of luteinizing hormone in man.

Authors:  C Hagen; A S McNeilly
Journal:  Acta Endocrinol (Copenh)       Date:  1975-04

4.  Radioimmunological characterization of human thyrotropin and its subunits: applications for the measurement of human TSH.

Authors:  M Binoux; J G Pierce; W D Odell
Journal:  J Clin Endocrinol Metab       Date:  1974-04       Impact factor: 5.958

5.  Secretion of alpha subunits of luteinizing hormone (LH) by the anterior pituitary.

Authors:  M Edmonds; M Molitch; J G Pierce; W D Odell
Journal:  J Clin Endocrinol Metab       Date:  1975-09       Impact factor: 5.958

6.  Plasma glycoprotein hormone alpha-subunit in the neonate and in prepubertal and pubertal children: effects of luteinizing hormone-releasing hormone.

Authors:  D M Styne; S L Kaplan; M M Grumbach
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

7.  Alpha chain of glycoprotein hormones: presence in human serum after thyroid stimulating hormone releasing hormone.

Authors:  R Benveniste; J Bell; J Koeppel; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

8.  Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders.

Authors:  I A Kourides; B D Weintraub; E C Ridgway; F Maloof
Journal:  J Clin Endocrinol Metab       Date:  1975-05       Impact factor: 5.958

9.  The effect of dehydroepiandrosterone sulfate on de novo and low-density lipoprotein-stimulated progesterone secretion by human choriocarcinoma JEG-3 cells.

Authors:  J Moise; J Ilekis; A Scommegna; R Benveniste
Journal:  Am J Obstet Gynecol       Date:  1986-05       Impact factor: 8.661

10.  Characterization of the human chorionic gonadotrophin fractions in pregnancy urine.

Authors:  D Puett; A Kenner; R Benveniste; D Rabinowitz
Journal:  Acta Endocrinol (Copenh)       Date:  1978-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.